|
|
Name: |
Logos Global Management LP |
City: |
San Francisco |
State: |
CA |
Zip: |
94104 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
70 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
IDYA |
Ideaya Biosciences, Inc. |
1 |
- |
$0.00 |
$65,820,000 |
1,500,000 |
6.93% |
1,776,000 |
-300,000 |
2.08 |
N/A |
|
IMCR |
Immunocore Holdings Adr |
2 |
- |
$50.47 |
$58,500,000 |
900,000 |
6.16% |
31,172,000 |
500,000 |
2.055 |
N/A |
|
IMVT |
Immunovant Inc |
3 |
- |
$0.00 |
$57,350,000 |
1,775,000 |
6.04% |
6,794,000 |
575,000 |
2.038 |
N/A |
|
OCUL |
Ocular Therapeutix, Inc |
4 |
- |
$0.00 |
$51,992,000 |
5,811,436 |
5.47% |
34,152,000 |
1,811,436 |
5.273 |
N/A |
|
SRPT |
Sarepta Therapeutics Inc |
5 |
- |
$128.30 |
$51,784,000 |
400,000 |
5.45% |
51,784,000 |
400,000 |
0.475 |
Drug Manufacturers - ... |
|
OLMA |
Olema Pharmaceuticals, Inc. |
6 |
- |
$0.00 |
$49,625,000 |
4,383,875 |
5.22% |
-4,752,000 |
0 |
7.955 |
N/A |
|
DYN |
Dyne Therapeutics, Inc. |
7 |
- |
$31.53 |
$49,115,000 |
1,730,000 |
5.17% |
24,111,000 |
-150,000 |
2.133 |
N/A |
|
APLS |
Apellis Pharmaceuticals Inc |
8 |
- |
$43.60 |
$47,024,000 |
800,000 |
4.95% |
-9,843,000 |
-150,000 |
0.699 |
N/A |
|
RCKT |
Rocket Pharmaceuticals |
9 |
- |
$22.44 |
$35,022,000 |
1,300,000 |
3.69% |
-3,190,000 |
25,000 |
1.404 |
N/A |
|
SLN |
Silence Therapeutics Adr Re... |
10 |
- |
$0.00 |
$31,086,000 |
1,476,061 |
3.27% |
24,138,000 |
1,076,061 |
4.952 |
N/A |
|
GPCR |
Structure Therapeutics Inc. |
11 |
- |
$36.38 |
$30,862,000 |
720,058 |
3.25% |
-12,754,000 |
-350,000 |
1.552 |
N/A |
|
GERN |
Geron Corporation |
12 |
- |
$3.66 |
$29,700,000 |
9,000,000 |
3.13% |
29,700,000 |
9,000,000 |
1.657 |
Drug Manufacturers - ... |
|
CLDX |
Celldex Therapeutics Inc |
13 |
New |
$38.10 |
$27,281,000 |
650,000 |
2.87% |
27,281,000 |
650,000 |
1.033 |
Diagnostic Substances |
|
ELVN |
Enliven Therapeutics Ord Shs |
14 |
- |
$0.00 |
$26,408,000 |
1,574,220 |
2.78% |
22,158,000 |
1,267,144 |
3.82 |
N/A |
|
VERA |
Vera Therapeutics, Inc. |
15 |
New |
$0.00 |
$24,794,000 |
575,000 |
2.61% |
24,794,000 |
575,000 |
1.358 |
N/A |
|
ANNX |
Annexon, Inc. |
16 |
- |
$0.00 |
$21,869,000 |
3,050,000 |
2.3% |
-604,000 |
-1,900,000 |
3.543 |
N/A |
|
ADVM |
Adverum Biotechnologies, Inc |
17 |
New |
$7.90 |
$21,210,000 |
1,499,999 |
2.23% |
21,210,000 |
1,499,999 |
1.485 |
N/A |
|
DSGN |
Design Therapeutics, Inc. |
18 |
- |
$0.00 |
$20,281,000 |
5,032,501 |
2.13% |
6,945,000 |
0 |
9.048 |
N/A |
|
AKRO |
Akero Therapeutics, Inc. |
19 |
- |
$0.00 |
$20,208,000 |
800,000 |
2.13% |
1,528,000 |
0 |
1.305 |
N/A |
|
ATXS |
Astria Therapeutics, Inc |
20 |
- |
$9.11 |
$17,523,000 |
1,244,960 |
1.84% |
13,338,000 |
700,000 |
2.277 |
N/A |
|
CYBN |
Cybin Inc |
21 |
New |
$0.36 |
$16,540,000 |
40,000,000 |
1.74% |
16,540,000 |
40,000,000 |
25.222 |
N/A |
|
XNCR |
Xencor Inc |
22 |
New |
$24.50 |
$14,385,000 |
650,000 |
1.51% |
14,385,000 |
650,000 |
0.979 |
Biotechnology |
|
CGON |
CG Oncology, Inc |
23 |
New |
$30.81 |
$13,170,000 |
300,000 |
1.39% |
13,170,000 |
300,000 |
0.455 |
N/A |
|
ENGN |
Engene Holdings Inc. |
24 |
New |
$13.22 |
$12,882,000 |
800,000 |
1.36% |
12,882,000 |
800,000 |
3.448 |
N/A |
|
KYTX |
Kyverna Therapeutics |
25 |
New |
$13.33 |
$12,420,000 |
500,000 |
1.31% |
12,420,000 |
500,000 |
1.163 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
26 |
- |
$12.70 |
$12,257,000 |
700,000 |
1.29% |
-811,000 |
100,000 |
1.116 |
N/A |
|
CGEM |
Cullinan Oncology Ord Shs |
27 |
New |
$0.00 |
$11,928,000 |
700,000 |
1.26% |
11,928,000 |
700,000 |
1.608 |
N/A |
|
IMTX |
Immatics N.V |
28 |
- |
$10.34 |
$10,510,000 |
1,000,000 |
1.11% |
10,510,000 |
1,000,000 |
1.59 |
N/A |
|
AGLE |
Aeglea Biotherapeutics, Inc. |
29 |
- |
$0.60 |
$9,483,000 |
250,000 |
1% |
6,255,000 |
100,000 |
0.409 |
N/A |
|
LCTX |
Lineage Cell Therapeutics O... |
30 |
New |
$0.92 |
$9,250,000 |
6,250,000 |
0.97% |
9,250,000 |
6,250,000 |
4.167 |
Biotechnology |
|
PRAX |
Praxis Precision Medicines,... |
31 |
New |
$0.00 |
$9,153,000 |
150,000 |
0.96% |
9,153,000 |
150,000 |
0.286 |
N/A |
|
APLT |
Applied Therapeutics Inc. |
32 |
- |
$0.00 |
$8,976,000 |
1,350,000 |
0.94% |
3,415,000 |
-310,000 |
1.748 |
N/A |
|
SNDX |
Syndax Pharmaceuticals Inc |
33 |
New |
$20.76 |
$8,330,000 |
350,000 |
0.88% |
8,330,000 |
350,000 |
0.372 |
N/A |
|
TRVI |
Trevi Therapeutics, Inc. |
34 |
New |
$0.00 |
$7,590,000 |
2,200,000 |
0.8% |
7,590,000 |
2,200,000 |
3.672 |
N/A |
|
CYTK |
Cytokinetics Inc |
35 |
- |
$59.23 |
$7,011,000 |
100,000 |
0.74% |
-128,660,000 |
-1,525,000 |
0.082 |
Biotechnology |
|
KURA |
Kura Oncology Inc |
36 |
New |
$22.55 |
$6,399,000 |
300,000 |
0.67% |
6,399,000 |
300,000 |
0.358 |
N/A |
|
NMRA |
Neumora Therapeutics, Inc. |
37 |
- |
$9.65 |
$6,193,000 |
382,345 |
0.65% |
-326,000 |
0 |
0.25 |
N/A |
|
LIFE |
aTyr Pharma Inc |
38 |
- |
$0.37 |
$6,045,000 |
3,100,000 |
0.64% |
-2,204,000 |
-2,750,000 |
5.294 |
N/A |
|
JANX |
Janux Therapeutics, Inc. |
39 |
New |
$0.00 |
$5,648,000 |
150,000 |
0.59% |
5,648,000 |
150,000 |
0.376 |
N/A |
|
ELEV |
Elevation Oncology, Inc. |
40 |
New |
$3.81 |
$5,130,000 |
1,000,000 |
0.54% |
5,130,000 |
1,000,000 |
2.358 |
N/A |
|
NXTC |
Nextcure, Inc. |
41 |
New |
$0.00 |
$4,293,000 |
1,925,000 |
0.45% |
4,293,000 |
1,925,000 |
6.987 |
N/A |
|
ALLK |
Allakos Inc. |
42 |
- |
$1.36 |
$3,654,000 |
2,900,000 |
0.38% |
-4,263,000 |
0 |
3.403 |
N/A |
|
UNCY |
Unicycive Therapeutics, Inc. |
43 |
New |
$0.00 |
$3,011,000 |
3,469,927 |
0.32% |
3,011,000 |
3,469,927 |
23.914 |
N/A |
|
BOLD |
Boundless Bio, Inc. |
44 |
New |
$11.02 |
$2,850,000 |
200,000 |
0.3% |
2,850,000 |
200,000 |
0.899 |
N/A |
|
TRML |
Tourmaline Bio |
45 |
- |
$0.00 |
$2,272,000 |
99,208 |
0.24% |
-5,173,000 |
-185,164 |
0.24 |
N/A |
|
CMPS |
Compass Pathways Plc |
46 |
- |
$0.00 |
$1,814,000 |
257,980 |
0.19% |
-2,561,000 |
-242,020 |
0.741 |
N/A |
|
IOBT |
Io Biotech, Inc. |
47 |
- |
$0.00 |
$854,000 |
493,827 |
0.09% |
-74,000 |
0 |
0.75 |
N/A |
|
IMUX |
Immunic Inc |
48 |
- |
$1.27 |
$556,000 |
421,184 |
0.06% |
-76,000 |
0 |
0.949 |
N/A |
|
LPTX |
Leap Therapeutics, Inc. |
49 |
- |
$2.50 |
$105,000 |
39,500 |
0.01% |
105,000 |
39,500 |
0.066 |
N/A |
|
NUVB.WS |
Nuvation Equity Warrants Ex... |
50 |
- |
$0.00 |
$23,000 |
66,666 |
0% |
19,000 |
0 |
0.741 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
57 |
Closed |
$0.00 |
$0 |
0 |
0% |
-10,393,000 |
-950,000 |
0 |
N/A |
|
AMAM |
Ambrx Biopharma Adr Represe... |
63 |
Closed |
$0.00 |
$0 |
0 |
0% |
-29,904,000 |
-2,100,000 |
0 |
N/A |
|
MLTX |
Multisys Language Solutions... |
53 |
Closed |
$0.00 |
$0 |
0 |
0% |
-9,059,000 |
-150,000 |
0 |
N/A |
|
RCUS |
Arcus Biosciences Inc |
69 |
Closed |
$16.75 |
$0 |
0 |
0% |
-6,208,000 |
-325,000 |
0 |
N/A |
|
VTYX |
Ventyx Biosciences, Inc. |
56 |
Closed |
$4.68 |
$0 |
0 |
0% |
-4,940,000 |
-2,000,000 |
0 |
N/A |
|
RVMD |
Revolution Medicines, Inc. |
62 |
Closed |
$39.77 |
$0 |
0 |
0% |
-10,038,000 |
-350,000 |
0 |
N/A |
|
RNA |
Avidity Biosciences, Inc. |
68 |
Closed |
$29.62 |
$0 |
0 |
0% |
-7,014,000 |
-775,000 |
0 |
N/A |
|
DCTH |
Delcath Systems Inc |
55 |
Closed |
$7.85 |
$0 |
0 |
0% |
-1,248,000 |
-300,000 |
0 |
Research Services |
|
ICVX |
Icosavax, Inc. |
54 |
Closed |
$0.00 |
$0 |
0 |
0% |
-4,728,000 |
-300,000 |
0 |
N/A |
|
MOR |
Morphosys Ag |
61 |
Closed |
$18.30 |
$0 |
0 |
0% |
-14,603,000 |
-1,475,000 |
0 |
N/A |
|
ARGX |
Argenx Se |
67 |
Closed |
$363.73 |
$0 |
0 |
0% |
-55,162,000 |
-145,000 |
0 |
N/A |
|
KRTX |
Karuna Therapeutics, Inc. |
60 |
Closed |
$0.00 |
$0 |
0 |
0% |
-28,486,000 |
-90,000 |
0 |
N/A |
|
XENE |
Xenon Pharmaceuticals Inc. |
66 |
Closed |
$0.00 |
$0 |
0 |
0% |
-6,909,000 |
-150,000 |
0 |
N/A |
|
FULC |
Fulcrum Therapeutics, Inc. |
59 |
Closed |
$0.00 |
$0 |
0 |
0% |
-8,100,000 |
-1,200,000 |
0 |
N/A |
|
RPTX |
Repare Therapeutics Inc. |
51 |
Closed |
$0.00 |
$0 |
0 |
0% |
-4,380,000 |
-600,000 |
0 |
N/A |
|
INBX |
Inhibrx, Inc. |
65 |
Closed |
$0.00 |
$0 |
0 |
0% |
-3,800,000 |
-100,000 |
0 |
N/A |
|
SLRN |
Acelyrin, Inc. |
58 |
Closed |
$4.52 |
$0 |
0 |
0% |
-9,325,000 |
-1,250,000 |
0 |
N/A |
|
RYZB |
Rayzebio, Inc. |
64 |
Closed |
$62.49 |
$0 |
0 |
0% |
-35,323,000 |
-568,173 |
0 |
N/A |
|
MORF |
Morphic Holding, Inc. |
52 |
Closed |
$29.26 |
$0 |
0 |
0% |
-5,776,000 |
-200,000 |
0 |
N/A |
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
70 |
Closed |
$19.27 |
$0 |
0 |
0% |
-2,631,000 |
-150,000 |
0 |
N/A |
|